Telemus Capital’s GSK GSK Stock Holding History

Telemus Capital’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-2	Closed	–	–	464
2017 Q4	$0	Buy	+2	New	+$92	﹤0.01%	602
2013 Q4	–	Sell	-3,358	Closed	-$211K	–	138
2013 Q3	$211K	Buy	+3,358	New	+$216K	0.06%	145

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Telemus Capital's GSK Position: Q1 2018 in Review

Telemus Capital sold out of GSK (GSK) in Q1 2018, closing a stake of 2 shares.

Telemus Capital first reported a position in GSK in Q3 2013 and held it in 2 quarters. The position peaked at $211K in Q3 2013. 778 funds tracked by Wall St. Rank hold GSK as of Q1 2018.

Telemus Capital reported no remaining GSK position as of Q1 2018 after selling out during the quarter.
Telemus Capital sold 2 GSK shares in Q1 2018.
Telemus Capital first reported a position in GSK in Q3 2013 and held it in 2 quarters.
Telemus Capital's GSK position peaked at $211K in Q3 2013.
778 funds tracked by Wall St. Rank held GSK as of Q1 2018.

Based on Telemus Capital's 13F filing for Q1 2018, filed 27 Apr 2018.